BIOHAVEN PHARMACEUTICAL
Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
BIOHAVEN PHARMACEUTICAL
Industry:
Biotechnology Health Care Health Diagnostics Neuroscience Pharmaceutical
Founded:
2013-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.biohavenpharma.com
Total Employee:
1001+
Status:
Active
Total Funding:
443.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA Cloudflare JS CDN JS
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Board_member
Board_member
2017-08-01
Board_member
Board_member
Current Employees Featured
Rob Berman Executive Officer & Co-Founder, Special Projects & Medical Oversight @ Biohaven Pharmaceutical
Executive Officer & Co-Founder, Special Projects & Medical Oversight
2019-01-01
James Engelhart Chief Financial Officer @ Biohaven Pharmaceutical
Chief Financial Officer
2016-05-01
Charles Conway Chief Scientific Officer @ Biohaven Pharmaceutical
Chief Scientific Officer
2017-01-01
William "BJ" Jones Chief Commercial Officer, Migraine & Common Diseases @ Biohaven Pharmaceutical
Chief Commercial Officer, Migraine & Common Diseases
2019-04-01
Vlad Coric Chief Executive Officer @ Biohaven Pharmaceutical
Chief Executive Officer
2015-10-01
Azim Munivar Medical Director @ Biohaven Pharmaceutical
Medical Director
Elyse Stock Chief Medical Officer @ Biohaven Pharmaceutical
Chief Medical Officer
2019-01-01
Robert Croop Chief Development Officer, Neurology @ Biohaven Pharmaceutical
Chief Development Officer, Neurology
2017-01-01
John Tilton Chief Commercial Officer @ Biohaven Pharmaceutical
Chief Commercial Officer
2016-04-01
Cliff Bechtold Chief Operating Officer @ Biohaven Pharmaceutical
Chief Operating Officer
2017-10-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-07 | Kleo | Kleo acquired by Biohaven Pharmaceutical | 20 M USD |
Investors List
Soros Fund Management
Soros Fund Management investment in Post-IPO Equity - Biohaven Pharmaceutical
Venrock
Venrock investment in Venture Round - Biohaven Pharmaceutical
RA Capital Management
RA Capital Management investment in Venture Round - Biohaven Pharmaceutical
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Biohaven Pharmaceutical
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Venture Round - Biohaven Pharmaceutical
Aisling Capital
Aisling Capital investment in Venture Round - Biohaven Pharmaceutical
Greg Bailey
Greg Bailey investment in Venture Round - Biohaven Pharmaceutical
Knoll Capital Management
Knoll Capital Management investment in Venture Round - Biohaven Pharmaceutical
Connecticut Innovations
Connecticut Innovations investment in Venture Round - Biohaven Pharmaceutical
Litmore Capital
Litmore Capital investment in Venture Round - Biohaven Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-01 | Artizan Biosciences | Biohaven Pharmaceutical investment in Series A - Artizan Biosciences | 18.88 M USD |
| 2018-11-14 | Kleo | Biohaven Pharmaceutical investment in Series B - Kleo | 21 M USD |
| 2016-09-01 | Kleo | Biohaven Pharmaceutical investment in Series A - Kleo | N/A |
Official Site Inspections
http://www.biohavenpharma.com Semrush global rank: 1.11 M Semrush visits lastest month: 29.03 K
- Host name: ec2-3-130-137-99.us-east-2.compute.amazonaws.com
- IP address: 3.130.137.99
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Biohaven Pharmaceutical"
Our People | Biohaven
Prior to Biohaven Taina, worked at Alexion Pharmaceuticals as an Executive Assistant supporting the CFO and various members of the executive team before transitioning to the Sourcing …See details»
Commitment to Patients, Winning with Science | Biohaven
CHALLENGING THE STATUS QUO. At Biohaven, we are guided by science and inspired to change the lives of people with unmet medical needs. Harnessing our non-hierarchical, …See details»
Biohaven - LinkedIn
Biohaven is a uniquely different pharmaceutical company. We are an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life …See details»
Biohaven Pharmaceutical
4 days ago https://www.biohavenpharma.com. Overview. Location. Table of content . Summary. History. Mission. Vision. Key Team. Recognition and Award. ... 2019 Technology Pioneer …See details»
Biohaven Pharmaceutical - Crunchbase Company Profile & Funding
Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders.See details»
Biohaven, Ltd. - CREATING SHAREHOLDER VALUE
Biohaven, Ltd. - CREATING SHAREHOLDER VALUESee details»
Biohaven Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biohaven Pharmaceuticals, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Biohaven Pharmaceuticals | Life Sciences PA - Default Site
Www.biohavenpharma.com; About. Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing …See details»
Biohaven Pharmaceutical - Craft
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. Biohaven obtained licenses from Yale University School of Medicine …See details»
Biohaven Pharmaceutical Holding Company Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biohaven Pharmaceutical Holding Company Ltd. of New Haven, CT. Get the latest business insights …See details»
Biohaven Pharmaceutical CEO and Key Executive Team - Craft
Biohaven Pharmaceutical's Senior Vice President, Clinical Operations is Kimberly Gentile. Other executives include Matthew Buten, Chief Financial Officer; Gregory H. Bailey, Director and 28 …See details»
Biohaven Pharmaceutical Holding Company, Ltd Information
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. Biohaven obtained licenses from Yale University School of Medicine …See details»
A Brief History of Biohaven Pharmaceutical
Oct 2, 2024 Founding and Origins of Biohaven. Biohaven Pharmaceutical was founded in 2013 by a group of experienced biopharmaceutical executives with a shared vision of developing …See details»
Biohaven Pharmaceutical Holding Company Ltd - Company …
Biohaven's team comprises experts with extensive experience in developing therapeutic agents for these conditions, including the originators who discovered the therapeutic potential of …See details»
Working at Biohaven Pharmaceuticals - Zippia
Mar 14, 2024 www.biohavenpharma.com. Organization Type. Public. CEO. Vladimir Coric. Social Media. Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late …See details»
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
Oct 3, 2022 Acquisition adds breakthrough calcitonin gene-related peptide portfolio, including NURTEC® ODT, to address needs of millions of migraine patients worldwide Pfizer Inc. …See details»
Biohaven Reports Recent Business Developments and Fourth …
Dec 31, 2024 Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven, commented, "We have made considerable progress this past year in advancing our innovative and …See details»
Biohaven Pharmaceutical Holding Company Ltd: Overview
Biohaven Pharmaceutical Holding Company Ltd (Biohaven) is a clinical-stage biopharmaceutical company. It develops late-stage product candidates for neurological diseases.See details»
Pfizer upgrades Biohaven alliance to a takeover bid
1 day ago Not content with a $1.2 billion licensing deal for Biohaven Pharma's oral migraine therapy rimegepant, Pfizer has just offered to buy the company outright – for a cool $11.6 billion.See details»
Biohaven - Overview, News & Similar companies | ZoomInfo.com
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares NEW HAVEN, Conn., Oct. 2, 2024 /PRNewswire/ -- Biohaven Ltd. …See details»